Analysts: Acura Pharmaceuticals Inc (ACUR.OQ)
ACUR.OQ on NASDAQ Stock Exchange Capital Market
1.98USD
1 Aug 2013
1.98USD
1 Aug 2013
Price Change (% chg)
$-0.06 (-2.94%)
$-0.06 (-2.94%)
Prev Close
$2.04
$2.04
Open
$1.99
$1.99
Day's High
$2.01
$2.01
Day's Low
$1.90
$1.90
Volume
57,968
57,968
Avg. Vol
92,365
92,365
52-wk High
$4.49
$4.49
52-wk Low
$1.06
$1.06
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.07 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 0 | 0 | 0 | -- |
| (2) OUTPERFORM | 1 | 1 | 1 | -- |
| (3) HOLD | 0 | 0 | 0 | -- |
| (4) UNDERPERFORM | 0 | 0 | 0 | -- |
| (5) SELL | 0 | 0 | 0 | -- |
| No Opinion | 0 | 0 | 0 | -- |
| Mean Rating | 2.00 | 2.00 | 2.00 | -- |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 1 | 0.11 | 0.11 | 0.11 | -- |
| Quarter Ending Dec-13 | 1 | 0.18 | 0.18 | 0.18 | -- |
| Year Ending Dec-13 | 1 | 0.36 | 0.36 | 0.36 | -- |
| Year Ending Dec-14 | 1 | 22.05 | 22.05 | 22.05 | -- |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 1 | -0.07 | -0.07 | -0.07 | -- |
| Quarter Ending Dec-13 | 1 | -0.07 | -0.07 | -0.07 | -- |
| Year Ending Dec-13 | 1 | -0.31 | -0.31 | -0.31 | -- |
| Year Ending Dec-14 | 1 | 0.12 | 0.12 | 0.12 | -- |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Jun-09 | 1.50 | 0.90 | 0.60 | 40.20 |
| Quarter Ending Mar-09 | 3.50 | 1.26 | 2.24 | 63.91 |
| Earnings (per share) | ||||
| Quarter Ending Jun-09 | -0.03 | -0.14 | 0.11 | -366.67 |
| Quarter Ending Mar-09 | -0.06 | -0.03 | 0.03 | -50.00 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 0.11 | 0.11 | 0.11 | 0.11 | -- |
| Quarter Ending Dec-13 | 0.18 | 0.18 | 0.18 | 0.18 | -- |
| Year Ending Dec-13 | 0.36 | 0.36 | 0.36 | 0.36 | -- |
| Year Ending Dec-14 | 22.05 | 22.05 | 22.05 | 22.05 | -- |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | -0.07 | -0.07 | -0.07 | -0.07 | -- |
| Quarter Ending Dec-13 | -0.07 | -0.07 | -0.07 | -0.07 | -- |
| Quarter Ending Dec-13 | -0.31 | -0.31 | -0.31 | -0.31 | -- |
| Quarter Ending Dec-14 | 0.12 | 0.12 | 0.12 | 0.12 | -- |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates